Ledger.Open graph →
SEC Form D · filed December 22, 2023

Cambrian BioPharma Inc

Offering
$40.0M
Sold
$7.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Maryanna G. Saenko · New York, NYDirectorBrenton G. Saunders · New York, NYDirectorChristian G. Angermayer · New York, NYDirectorPaul G. Farr · New York, NYDirectorJames G. Peyer · New York, NYExec · DirectorAron Shapiro · Encinitas, CADirectorBrenton G. Saunders · New York, NYDirectorAnton Zietsman · Santa Monica, CADirectorTravis Kell · Santa Monica, CAExec · DirectorPaul G. Farr · New York, NYDirectorJeffery C. Schneider · MOORESTOWN, NJExec · DirectorRobert S. Newell · Las Vegas, NVDirectorMatthew Gaylord · Waltham, MADirectorJohn D. Lerosen · PACIFIC PALISADES, CADirectorBrian D. Martin · PACIFIC PALISADES, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗